Konsomasyon kafe ka ogmante risk ou genyen pou kans\u00e8.<\/span><\/p>\n\n Bw\u00e8 kafe pa yon k\u00f2z kans\u00e8 nan tete, pankreyas, oswa pwostat e li ka menm diminye risk pou kans\u00e8 andometriyal, t\u00e8t ak kou, kolorektal, ak fwa<\/span> (ACS)<\/span><\/a> . Genyen pr\u00e8v tou ki montre ke bw\u00e8 kafe lye ak yon pi ba risk pou rezistans ensilin ak dyab\u00e8t tip 2<\/span> (ACS)<\/span><\/a> . Plizy\u00e8 etid epidemyolojik montre ke konsomasyon kafe pa ogmante risk kans\u00e8<\/span> (Zhao)<\/span><\/a> .<\/span><\/p>\n\n Anpil nan enkyetid kons\u00e8nan konsomasyon kafe ak kans\u00e8 soti nan lef\u00e8t ke kafe ka gen yon pwodui chimik yo rele akrilamid, ki f\u00f2me pandan pwosesis torrefyasyon an. Yo montre akrilamid lak\u00f2z kans\u00e8 nan b\u00e8t ki ekspoze a d\u00f2z tr\u00e8 wo<\/span> (ACS)<\/span><\/a> . Etid sa yo konkli ke konsomasyon kafe<\/span> pa<\/span> lak\u00f2z kans\u00e8 nan sourit ( IARC<\/a> ).<\/span><\/p>\n\n Gwoup 3 (Pa ka klase selon kanseroj\u00e8nite li pou moun)<\/span><\/p>\n\n Sanble gen benefis pou sante l\u00e8 w bw\u00e8 kafe. Si w ap enkyete w pou ekspozisyon akrilamid, ou ka diminye epi limite kantite manje w ap manje ki kuit nan tanperati ki wo (pandan w ap fri, griye, ak boulanje) pou pery\u00f2d tan ki pi long<\/span> (ACS)<\/span><\/a> .<\/span><\/p>\n\n Bw\u00e8 kafe lye av\u00e8k yon risk pi ba pou kans\u00e8 andometriyal, kans\u00e8 nan t\u00e8t ak kou, kans\u00e8 kolorektal, ak kans\u00e8 nan fwa. Bw\u00e8 kafe kapab tou diminye risk rezistans ensilin ak dyab\u00e8t tip 2. <\/p>\n\nSa syans di nou<\/h2>\n\n
Pr\u00e8v Epidemyolojik<\/h3>\n\n
Pr\u00e8v Laboratwa\/Pr\u00e8v Sip\u00f2<\/h3>\n\n
Klasifikasyon kanseroj\u00e8n IARC: <\/h3>\n\n
Kijan pou diminye risk ou<\/h2>\n\n
Liy final la<\/h2>\n\n
<\/h2>\n\n